Universal Ibogaine Inc has seen no price movement this week amidst ongoing restructuring efforts.
Universal Ibogaine Inc (IBO.V) has remained stagnant in its stock performance, closing at C$0.01 with no change over the past week. The company continues to navigate challenges related to its restructuring process and financial reporting.
Advertisement
Universal Ibogaine Inc
IBO.V
IBO.V
Universal Ibogaine Inc
WealthAwesomeMarket cap
$1.56M
P/E
0.0x
52W high
$0.01
52W low
$0.01
1W change
+0.00%
Beta
4.28
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on IBO's historical volatility
30-Day Vol
0.0%
Annualized
90-Day Vol
0.0%
Annualized
Trend (90d)
+0.0%
Annualized drift
90d Mean
C$0.01
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.01 | C$0.01 – C$0.01 |
| 60 trading days | C$0.01 | C$0.01 – C$0.01 |
| 90 trading days | C$0.01 | C$0.01 – C$0.01 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should monitor Universal Ibogaine's restructuring updates and financial filings closely, as these factors could significantly impact future performance.
Market Cap Stands at C$1.56 Million
Despite a small market cap, Universal Ibogaine's focus on addiction treatment positions it in a growing health care niche, although profitability remains a concern with a negative profit margin.
Bull case
If Universal Ibogaine successfully completes its restructuring and secures necessary funding, it could stabilize operations and enhance its value in the addiction treatment sector.
Bear case
Delays in financial filings and ongoing restructuring challenges could further strain investor confidence and lead to more volatility in the stock.
Price Action Overview
Advertisement
This week, Universal Ibogaine Inc's stock price remained unchanged at C$0.01. The performance metrics show a 1D change of +0.00%, with a 1W and 1M performance also at +0.00%. Year-to-date, the stock has not gained or lost value, indicating a period of stagnation.
Company News and Developments
Recent headlines indicate that Universal Ibogaine is in the midst of a restructuring process. The company has provided updates regarding delays in its financial filings, including a bi-weekly default status report. This ongoing restructuring is critical for the company's future, particularly as it seeks to stabilize operations and address financial challenges.
Technical Picture
Looking at the technical indicators, Universal Ibogaine's 50-day moving average is C$0.01, which is consistent with its current price. However, the 200-day moving average is C$0.01, showing a decline of 12.3% compared to the current price. The stock has a 52-week range between C$0.01 and C$0.02, indicating it is currently at the lower end of this range. With a beta of 4.34, the stock is considered highly volatile, which may be a concern for risk-averse investors.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
